Furthermore, prostate cancer progression has been shown to be inhibited in mice and in a subcutaneous tumour xenograft mouse model by the intraprostatic and intertumoral injection of recombinant adeno-associated virus 9 expressing PTEN [166]. This evidence concerns the gene PTEN and prostate carcinoma.